Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 16 (6) , 386-390
- https://doi.org/10.1016/s1056-8727(02)00162-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibitionDiabetic Medicine, 2001
- Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney diseaseDiabetologia, 2000
- Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complicationsDiabetic Medicine, 2000
- Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.Diabetes, 1999
- Pathogenesis, prevention, and treatment of diabetic nephropathyThe Lancet, 1998
- Modulation of VEGF production by pH and glucose in retinal Müller cellsCurrent Eye Research, 1998
- Vascular Endothelial Growth Factor and Severity of Nonproliferative Diabetic Retinopathy Mediate Retinal Hemodynamics In Vivo: A Potential Role for Vascular Endothelial Growth Factor in the Progression of Nonproliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1997
- Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathyDiabetologia, 1997
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.BMJ, 1987